Seeking Alpha

Joe Springer

 
View as an RSS Feed
View Joe Springer's Comments BY TICKER:
Latest comments  |  Highest rated
  • Solazyme: In The Wrong Place At The Wrong Time [View article]
    I think the anonymous author and empty arguments tell us that this is some tree-shaking/ bear-raiding, no authentic attempt at a fair evaluation here.
    Nov 1 02:22 AM | 5 Likes Like |Link to Comment
  • Tonix May Not Need Final Trial [View article]
    "there is not alot of data for this drug "

    Cyclobenzaprine has been on the market since it was approved in 1977, and at doses more than 10 times TNX-102 SL. Its safety profile is excellent. How many drugs that have ever come up for approval already had 4 decades of safe use?
    Aug 8 11:30 PM | 4 Likes Like |Link to Comment
  • Tonix May Not Need Final Trial [View article]
    Thank you for the observation about your girlfriend Alpha Sponge, always good to hear the real life anecdotes. I hope TNX-102 SL can help you and yours in many ways. And thank you for serving.
    Aug 8 03:43 PM | 4 Likes Like |Link to Comment
  • The Best Passive Retirement Strategy In The World [View article]
    Well, I did say "shoot this apart"
    Jun 26 06:18 PM | 4 Likes Like |Link to Comment
  • The Best Passive Retirement Strategy In The World [View article]
    Whoops, I changed the example a number of times, I bet I had it right at some point!

    Well that's good news, you can do all this AND start your retirement off with a $52,500 car!
    Jun 26 03:55 PM | 4 Likes Like |Link to Comment
  • Tonix Approaching 100 Days Until BESTFIT Results [View article]
    I've called E-Trade for months, including this week (they called me), and Dr. Gershell called them as well, yesterday I told Dr. Gershell again and he said he would have the I-can't-remember-who call them, maybe Investor Relations, but E-Trade keeps saying they have no info, the guy told me this week that he would get it removed if he could or else tell me why not, we will see.
    Jun 20 11:15 AM | 4 Likes Like |Link to Comment
  • Tonix Approaching 100 Days Until BESTFIT Results [View article]
    The options market for Tonix is not nearly big enough to accommodate much less hide a bunch of illegal insider activity. 40 calls of open interest, meaning 4,000 shares? Prison for that instead instead of sitting tight and becoming the next Celgene or getting bought out? The chairman of Columbia medical school is one of the two founders, the other is the CEO and largest shareholder...you and petepanzer must sit in a hair salon all day coming up with this!! : )
    Jun 19 08:39 PM | 4 Likes Like |Link to Comment
  • Tonix to be added to MSCI micro-cap index [View news story]
    That's like a buyback on the small float, kudos!
    May 28 02:56 PM | 4 Likes Like |Link to Comment
  • Seattle Super-Tonix  [View instapost]
    Well, the Chairman's name is John Pappajohn, so management gets an A+:

    http://seekingalpha.co...
    Jan 14 11:56 AM | 4 Likes Like |Link to Comment
  • Hydrogen Stocks More Than Double In 2013: Why The Pros Missed The Ride [View article]
    Tom what is the real institutional number on HYGS? You noted the growth. Does that bring the total to 55% or 60%?

    What do you think of their fuel station construction and service business? They are the world leader, that is a nice double dip way to play the roll out.

    What do you think of their power-to-gas business? That has more upside than any of the fuel cell businesses, which have lot of upside themselves.
    Dec 18 01:21 PM | 4 Likes Like |Link to Comment
  • 4 Reasons Tonix Could Be A Multi-Bagger [View article]
    From the article Argyll:

    "B) Tonix Has Valuable Intellectual Property

    PK Patent

    While Tonix has a method of use patent for TNX-102 SL, it also has an active patenting strategy, and has filed a number of patents to extend TNX-102 SL exclusivity and expand its reach.

    By far the most important of these patents is the pharmacokinetics (PK) patent filed in June of 2012 that should guarantee market exclusivity for TNX-102 SL through 2032.

    A PK patent refers to the curve that shows how much drug is in the blood at certain times after administration

    PK patents are sometimes called "Oxycontin patents" because Purdue Pharmaceuticals got strong patent protection using Oxycontin's PK profile. Oxycontin survived every court challenge by generics, even though it was a reformulation of 95-year-old Oxycodone, and those patents beat every challenge and expired naturally.

    The company that filed and defended Purdue's patents was Ropes & Gray, and that is who Tonix hired to file and defend its patents.

    These types of PK patents have proven very difficult to circumvent in court. Tonix's intellectual property around TNX-102 SL should guarantee market exclusivity until at least 2032."
    Dec 9 09:07 AM | 4 Likes Like |Link to Comment
  • My 80 Year Prediction On 3D Printing And Robotics [View article]
    Superior peasant-machines could be developed to revolt more efficiently than regular peasants..
    Oct 10 09:54 PM | 4 Likes Like |Link to Comment
  • 6 Reasons ImmunoCellular Therapeutics Is One Of The Best Risk Vs. Rewards In The Market [View article]
    The company has visibility through the end of the year for expense - should spend a million a month and not raise funds prior to ICT-107's fate being decided at FDA meeting. The earnings tomorrow are very unlikely to have any surprises.
    Aug 6 01:46 PM | 4 Likes Like |Link to Comment
  • 5 Reasons Hydrogenics Could Triple [View article]
    It has been an arduous road here, no doubt. They got new management six years ago and the new CEO's work is now paying off, he came from Toyota Canada and brought standardization and simplification to HYGS - fuel cell costs dropped by 85%, electrolysers by 50%. Hang in there, after 16 years they are arriving!
    May 25 03:21 PM | 4 Likes Like |Link to Comment
  • 5 Reasons Hydrogenics Could Triple [View article]
    Historical performance as a guide for emerging technology - HYGS did not have Power-to-Gas at all in its history, and they've cut their fuel cell costs by 85% bringing commercialization at long last. Their backlog alone should bring profitability.
    May 24 07:33 PM | 4 Likes Like |Link to Comment
COMMENTS STATS
2,169 Comments
1,397 Likes